NMDA Receptor Antibody, Serum Test
NMDA Receptor Antibody, Serum Test
N-Methyl-D-Aspartate (NMDA) Receptor Antibodies target NR1 subunits of NMDA receptors, which are critical for synaptic transmission and brain function. The NMDA Receptor Antibody, Serum Test detects these autoantibodies in blood, aiding in the diagnosis of anti-NMDA receptor encephalitis, a severe autoimmune neurological disorder.
Anti-NMDA receptor encephalitis is commonly associated with paraneoplastic syndromes, especially ovarian teratomas, but can also occur without an underlying tumor. Early detection in serum helps initiate immunotherapy and guide further cerebrospinal fluid (CSF) testing, which is considered more specific for the condition.
What is the NMDA Receptor Antibody, Serum Test Used For?
This test is used to:
- Screen for anti-NMDA receptor encephalitis in patients with neuropsychiatric symptoms.
- Differentiate between autoimmune, psychiatric, and infectious neurological disorders.
- Aid in early diagnosis before CSF testing, particularly in suspected cases.
Guide further investigations, including lumbar puncture and tumor screening.
Symptoms of Anti-NMDA Receptor Encephalitis
Patients with NMDA receptor encephalitis may present with
Psychiatric disturbances (hallucinations, paranoia, agitation)
Seizures
Memory loss and confusion
Speech dysfunction (mutism, disorganized speech)
Autonomic instability (irregular heartbeat, blood pressure fluctuations)
Movement disorders (dystonia, rigidity, tremors)
Decreased level of consciousness or coma
Preparation for the Test
No special preparation is required. A blood sample is collected via venipuncture. Patients with suspected encephalitis may also require CSF analysis, MRI, or EEG.
Interpretation of Results
- Positive NMDA Receptor Antibodies in Serum: Suggests possible autoimmune encephalitis but requires CSF confirmation for a definitive diagnosis.
- Negative Result: Does not rule out the condition; CSF testing may still be needed.
- Higher Antibody Titers: Often correlate with disease severity and neurological dysfunction.
FAQs
How does this test compare to the CSF NMDA receptor antibody test?
Serum testing is useful for initial screening, but CSF testing is more specific and necessary for a definitive diagnosis.
Can anti-NMDA receptor encephalitis be mistaken for a psychiatric illness?
Yes, many cases are initially misdiagnosed as psychotic disorders, delaying proper treatment.
What treatments are available for this condition?
Treatment includes immunotherapy (steroids, IVIG, plasmapheresis), tumor removal if applicable, and long-term neurological care.
What other tests may be needed for diagnosis?
CSF analysis, MRI, EEG, tumor screening (ovarian ultrasound, CT scan) may be required.
How long does recovery take?
Recovery can take months to years, with possible relapses; early treatment improves prognosis.
Related tests
Tests At Lupin Diagnostics